Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2021
[Pharmacological characteristics and clinical study results of Pemigatinib (Pemazyre® Tablets), a selective fibroblast growth factor receptor (FGFR) inhibitor]Koki Kabu, Satoko Takei, Midori Kondo, et al.Internal Medicine (Tokyo, Japan)|May 15, 2022
Delayed Vasovagal Reaction with Reflex Syncope Following COVID-19 VaccinationBonpei Takase, Katsumi Hayashi, Satoko Takei, et al.Antioxidants & Redox Signaling|January 9, 2008
Redox-regulated mechanisms in asthmaTomoaki Hoshino, Masaki Okamoto, Satoko Takei, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 18, 2025
Morphologic variation of the circle of Willis is associated with cognitive impairment in a general population: The J-SHIPP studyYoko Okada, Yasuharu Tabara, Katsuhiko Kohara, et al.Archives of Gerontology and Geriatrics|April 23, 2022
Dermal advanced glycation end-product accumulation is associated with sarcopenia-related measures in middle-aged and older menSayaka Matsumoto, Masayuki Ochi, Yuji Akechi, et al.No to Hattatsu = Brain and Development|August 1, 2012
[The effect of noninvasive positive pressure ventilation in children with severe motor and intellectual disabilities with respiratory insufficiency]Shuji Matsui, Gen Nakagawa, Satoko Takei, et al.Allergology International : Official Journal of the Japanese Society of Allergology|June 23, 2009
Endogenous and exogenous thioredoxin 1 prevents goblet cell hyperplasia in a chronic antigen exposure asthma modelHaruki Imaoka, Tomoaki Hoshino, Masaki Okamoto, et al.Biochemical and Biophysical Research Communications|July 6, 2007
Effects of thioredoxin on established airway remodeling in a chronic antigen exposure asthma modelHaruki Imaoka, Tomoaki Hoshino, Satoko Takei, et al.American Journal of Respiratory and Critical Care Medicine|April 3, 2007
Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13Tomoaki Hoshino, Seiya Kato, Naoki Oka, et al.Arthritis Research & Therapy|March 26, 2011
Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritisSatoko Takei, Tomoaki Hoshino, Kazuko Matsunaga, et al.Pageof 2